Merck KGaA Sponsored ADR (MKKGY)
OTHER OTC:MKKGY
Want to see MKKGY full AI Analyst Report?
Earnings Data
Report Date
Aug 06, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.47Last Year’s EPS
0.47Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call paints a generally constructive picture: organic performance and profitability improved (notably in Life Science and semiconductor materials), operating cash flow and net debt improved, and management upgraded full‑year guidance. However, reported results were weighed down by FX and portfolio effects, Healthcare faces meaningful product‑specific pressures (Mavenclad generics) and EPS was notably lower year‑on‑year. Electronics profitability was also boosted by one‑offs. On balance the positives (organic growth, upgraded guidance, strong cash flow and strategic clarity/M&A execution) outweigh the negatives, though there are clear near‑term risks from FX, healthcare headwinds and some Q1 phasing effects.Company Guidance
Group Organic Growth and Profitability Improvement
Organic group sales grew ~+2.9% (reported as ~+3% by management) and organic EBITDA pre increased ~+5%–+5.3% year‑on‑year. Underlying EBITDA pre margin improved ~70 basis points to 29.8%.
Life Science Outperformance
Life Science delivered strong organic sales growth of +8.3% in Q1, with Process Solutions up +16% in the quarter and exceeding EUR 1 billion in sales for the quarter (first time since Q1 2023). Life Science EBITDA pre rose ~+7.4% organically with a ~50 bp margin expansion.
Electronics Growth in Semiconductor Materials
Electronics achieved organic sales growth of +4.2%; Semiconductor Solutions (semiconductor materials) grew ~+7.5% organically with low double‑digit growth in semiconductor materials driven by AI and advanced nodes. Electronics EBITDA pre rose strongly (+30.1% organically), with reported margin at 34.6% (note: partially driven by one‑offs).
Upgraded Full‑Year Guidance
Management raised 2026 guidance: sales now expected at EUR 20.4–21.4 billion and EBITDA pre EUR 5.7–6.1 billion. Implied group organic sales growth moved to 0% to +3% (up from -1% to +2%); EPS pre guidance increased to EUR 7.50–8.20 (from EUR 7.10–8.00).
Strong Cash Flow and Deleveraging
Operating cash flow improved materially (year‑on‑year increase ~+47% to ~EUR 818 million), and net financial debt decreased ~‑3.5% to EUR 8.318 billion, reflecting strong operating cash flow and disciplined capex.
Strategic M&A and Capability Expansion
Closed acquisition of JSR (April 3) to broaden downstream protein A chromatography capabilities; management reiterated a clear strategic direction to prioritize high‑growth value drivers, integrated workflow solutions, platform capabilities and disciplined M&A/in‑licensing.
Dividend Approved
Shareholders approved a dividend proposal of EUR 2.20 per share at the AGM (April 24).
Order Momentum and Book‑to‑Bill Strength in Life Science
Order intake in Life Science remained strong in Q1 with book‑to‑bill comfortably above 1, and management expects Process Solutions underlying growth to remain around midterm aspiration (~10%) over time.
MKKGY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
MKKGY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 13, 2026 | $26.52 | $28.37 | +6.97% |
Mar 05, 2026 | $28.26 | $25.87 | -8.46% |
Nov 13, 2025 | $26.47 | $27.89 | +5.38% |
Aug 07, 2025 | $24.21 | $23.99 | -0.94% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Merck KGaA Sponsored ADR (MKKGY) report earnings?
Merck KGaA Sponsored ADR (MKKGY) is schdueled to report earning on Aug 06, 2026, Before Open (Confirmed).
What is Merck KGaA Sponsored ADR (MKKGY) earnings time?
Merck KGaA Sponsored ADR (MKKGY) earnings time is at Aug 06, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MKKGY EPS forecast?
MKKGY EPS forecast for the fiscal quarter 2026 (Q2) is 0.47.